Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05904_nanopub.RAcQW4C0_cvV4Ww239AvWmbya9K8FmTgAqrb2AMI8k1TI#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05904 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05904 label "BLX-883 [drugbank:DB05904]" assertion.
- drugbank:DB05904 seeAlso DB05904 assertion.
- drugbank:DB05904 description "BLX-883 is a form of alfa interferon developed by Biolex for the treatment of hepatitis viral C. Alfa interferon is used in the treatment of hepatitis C, hepatitis B, and multiple cancers and its worldwide sales currently exceed $3 billion." assertion.
- drugbank:DB05904 identifier "drugbank:DB05904" assertion.
- drugbank:DB05904 title "BLX-883" assertion.
- drugbank:DB05904 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05904 drugbank_vocabulary:drugbank-id "DB05904" assertion.
- drugbank:DB05904 bio2rdf_vocabulary:x-identifiers.org DB05904 assertion.
- drugbank:DB05904 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05904" assertion.
- drugbank:DB05904 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05904 bio2rdf_vocabulary:identifier "DB05904" assertion.